an.amankwah
Submits third-party assay reports on material purchased directly. Based in Nantes.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.90%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042984 | Desmopressin | KP | KP-2512-U5139 | Janoshik | 2026-Q2 | 99.09 | 2.79 | 93.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041701 | Semaglutide | QSC | QSC-2604-H9231 | Janoshik | 2026-Q2 | 99.42 | 6.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043162 | Retatrutide | SSA | SSA-2601-T7702 | Medutest | 2026-Q1 | 98.70 | 5.82 | 106.4 | Supplier-supplied | 3 | FAIL |
| AX-2026-041675 | Ipamorelin | QSC | QSC-2602-W8804 | Janoshik | 2026-Q1 | 99.38 | 5.75 | 90.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019517 | MK-677 (Ibutamoren mesylate) | Homopeptide | HOMO-2506-L9801 | Nordanalyt | 2025-Q4 | 99.78 | 1.30 | — | Laboratory-retained | 1 | FAIL |
| AX-2025-020035 | Retatrutide | ERP | ERP-2506-C7220 | Kestrel | 2025-Q3 | 98.54 | 4.95 | — | Buyer-sourced | 3 | FAIL |
| AX-2025-020484 | Sermorelin | KP | KP-2501-V5157 | Kestrel | 2025-Q1 | 98.90 | 5.67 | 104.2 | Supplier-supplied | 0 | PASS |
| AX-2024-005255 | Ipamorelin | SSA | SSA-2404-U7946 | Janoshik | 2024-Q3 | 97.83 | 4.64 | 101.7 | Supplier-supplied | 2 | FAIL |
| AX-2024-004312 | Tirzepatide | QYB | QYB-2403-T5291 | Janoshik | 2024-Q3 | 98.88 | 4.62 | — | Supplier-supplied | 2 | MARGINAL |